Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance-Reference-Cited by-同舟云学术

Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance

Published:2020-12 Issue: Volume:101 Page:24-28
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Gioia Francesca,Gomez-Lopez Alicia,Alvarez Maria Elena,Gomez-García de la Pedrosa Elia,Martín-Davila Pilar,Cuenca-Estrella Manuel,Moreno Santiago,Fortun Jesús

Funder

Instituto de Salud Carlos III

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference31 articles.

1. Anidulafungin dosing in critically ill patients with continuous venovenous haemodiafiltration;Aguilar;J Antimicrob Chemother,2014

2. Pharmacokinetics of anidulafungin during albumin dialysis;Aguilar;Crit Care,2014

3. In vivo comparison of the pharmacodynamic target among echinocandin drugs and Candida species;Andes;Antimicrob Agents Chemother,2010

4. Use of pharmacokinetic-pharmacodynamic analyses to optimize therapy with the systemic antifungal micafungin for invasive candidiasis or candidemia;Andes;Antimicrob Agents Chemother,2011

5. A research agenda on the management of intraabdominal candidiasis: results from a consensus of multinational experts;Bassetti;Intensive Care Med,2013

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use;World Journal of Emergency Surgery;2024-06-08

2. Intra-abdominal infections survival guide: a position statement by the Global Alliance For Infections In Surgery;World Journal of Emergency Surgery;2024-06-08

3. Therapeutic drug monitoring of antifungal therapies: do we really need it and what are the best practices?;Expert Review of Clinical Pharmacology;2024-02-21

4. Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis;Critical Care;2023-11-20

5. Critical appraisal beyond clinical guidelines for intraabdominal candidiasis;Critical Care;2023-10-03